ClinicalThought

Share

Program Content

Activities

  • Tazemetostat for R/R FL
    My Take on the Recent Approval of Tazemetostat for Relapsed/Refractory Follicular Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 04, 2020

    Expires: August 03, 2021

  • Updated FL Tool
    An Updated Interactive Treatment Decision Support Tool for Follicular Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 18, 2021

    Expires: March 17, 2025

Faculty

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Celgene

Epizyme, Inc.